CMMB
Price
$1.17
Change
-$0.02 (-1.68%)
Updated
Jun 27 closing price
Capitalization
22.42M
40 days until earnings call
ORKA
Price
$11.08
Change
-$0.55 (-4.73%)
Updated
Jun 27 closing price
Capitalization
414.84M
Interact to see
Advertisement

CMMB vs ORKA

Header iconCMMB vs ORKA Comparison
Open Charts CMMB vs ORKABanner chart's image
Chemomab Therapeutics
Price$1.17
Change-$0.02 (-1.68%)
Volume$69.88K
Capitalization22.42M
Oruka Therapeutics
Price$11.08
Change-$0.55 (-4.73%)
Volume$3.74M
Capitalization414.84M
CMMB vs ORKA Comparison Chart in %
Loading...
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CMMB vs. ORKA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CMMB is a Buy and ORKA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (CMMB: $1.17 vs. ORKA: $11.08)
Brand notoriety: CMMB and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CMMB: 45% vs. ORKA: 1656%
Market capitalization -- CMMB: $22.42M vs. ORKA: $414.84M
CMMB [@Biotechnology] is valued at $22.42M. ORKA’s [@Biotechnology] market capitalization is $414.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CMMB’s FA Score shows that 1 FA rating(s) are green whileORKA’s FA Score has 1 green FA rating(s).

  • CMMB’s FA Score: 1 green, 4 red.
  • ORKA’s FA Score: 1 green, 4 red.
According to our system of comparison, ORKA is a better buy in the long-term than CMMB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CMMB’s TA Score shows that 3 TA indicator(s) are bullish while ORKA’s TA Score has 3 bullish TA indicator(s).

  • CMMB’s TA Score: 3 bullish, 6 bearish.
  • ORKA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ORKA is a better buy in the short-term than CMMB.

Price Growth

CMMB (@Biotechnology) experienced а -2.50% price change this week, while ORKA (@Biotechnology) price change was -5.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CMMB is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORKA($415M) has a higher market cap than CMMB($22.4M). CMMB YTD gains are higher at: -35.359 vs. ORKA (-42.857). ORKA has more cash in the bank: 349M vs. CMMB (10.6M). CMMB has less debt than ORKA: CMMB (292K) vs ORKA (947K).
CMMBORKACMMB / ORKA
Capitalization22.4M415M5%
EBITDA-14.18MN/A-
Gain YTD-35.359-42.85783%
P/E RatioN/AN/A-
Revenue0N/A-
Total Cash10.6M349M3%
Total Debt292K947K31%
FUNDAMENTALS RATINGS
CMMB vs ORKA: Fundamental Ratings
CMMB
ORKA
OUTLOOK RATING
1..100
7351
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
5
Undervalued
PROFIT vs RISK RATING
1..100
99100
SMR RATING
1..100
98100
PRICE GROWTH RATING
1..100
6343
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORKA's Valuation (5) in the null industry is in the same range as CMMB (30) in the Biotechnology industry. This means that ORKA’s stock grew similarly to CMMB’s over the last 12 months.

CMMB's Profit vs Risk Rating (99) in the Biotechnology industry is in the same range as ORKA (100) in the null industry. This means that CMMB’s stock grew similarly to ORKA’s over the last 12 months.

CMMB's SMR Rating (98) in the Biotechnology industry is in the same range as ORKA (100) in the null industry. This means that CMMB’s stock grew similarly to ORKA’s over the last 12 months.

ORKA's Price Growth Rating (43) in the null industry is in the same range as CMMB (63) in the Biotechnology industry. This means that ORKA’s stock grew similarly to CMMB’s over the last 12 months.

ORKA's P/E Growth Rating (100) in the null industry is in the same range as CMMB (100) in the Biotechnology industry. This means that ORKA’s stock grew similarly to CMMB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CMMBORKA
RSI
ODDS (%)
Bullish Trend 3 days ago
89%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
68%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
77%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 13 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
56%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
CMMB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORKA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WKRCF27.551.15
+4.36%
Wacker Neuson SE
PEBC58.000.40
+0.69%
Peoples Bancorp Inc.
STRNY38.280.02
+0.06%
Severn Trent PLC
ANOYX23.51-0.01
-0.04%
American Century Small Cap Growth Y
CURN14.48-0.02
-0.14%
Currency Exchange International Corp

CMMB and

Correlation & Price change

A.I.dvisor indicates that over the last year, CMMB has been loosely correlated with OVID. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if CMMB jumps, then OVID could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMMB
1D Price
Change %
CMMB100%
-1.98%
OVID - CMMB
33%
Loosely correlated
-11.95%
COGT - CMMB
30%
Poorly correlated
-3.14%
LGVN - CMMB
29%
Poorly correlated
+1.54%
GLPG - CMMB
29%
Poorly correlated
+0.97%
ARWR - CMMB
28%
Poorly correlated
+0.06%
More

ORKA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORKA has been loosely correlated with HLOSF. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ORKA jumps, then HLOSF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORKA
1D Price
Change %
ORKA100%
-4.73%
HLOSF - ORKA
62%
Loosely correlated
N/A
PCVX - ORKA
43%
Loosely correlated
-0.91%
RLFTF - ORKA
32%
Poorly correlated
N/A
ENTX - ORKA
29%
Poorly correlated
-1.00%
CMMB - ORKA
25%
Poorly correlated
-1.98%
More